Improving outcomes in infants of HIV-infected women in a developing country setting

PLoS ONE

Volumn 3, Issue 11, 2008, Pages

  Noel, Francine ^a   Mehta, Sapna ^b   Zhu, Yuwei ^b   De Matteis Rouzier, Patricia ^a   Marcelin, Abdias ^a   Shi, Jian R ^b   Nolte, Claudine ^a   Severe, Linda ^a   Deschamps, Marie Marcelle ^a   Fitzgerald, Daniel W ^c   Johnson, Warren D ^c   Wright, Peter F ^b,d   Pape, Jean W ^a,c  

^a Department of Adolescent Medicine   (Haïti)

^b VANDERBILT UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CHILD; CHILD CARE; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT FEEDING; INFANT MORTALITY; INFECTION CONTROL; INFECTION RATE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL WELFARE; MONOTHERAPY; MORTALITY; MOTHER CHILD RELATION; PROGNOSIS; SHORT COURSE THERAPY; VIRUS TRANSMISSION; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; NEWBORN; NEWBORN DISEASE; PHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; RISK FACTORS; TREATMENT OUTCOME;

EID: 56649112734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003723     Document Type: Article

References (44)

1. UNAIDS/WHO (2007) AIDS Epidemic Update.
2. (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40: 458-465.
3. (2006) Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep 55: 592-597.
4. Mofenson LM (2002) U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 51: 1-38; quiz CE31-34.
5. Mofenson LM (2003) Tale of two epidemics-the continuing challenge of preventing mother-to-child transmission of human immunodeficiency virus. J Infect Dis 187: 721-724.
6. Morris K (1998) Short course of AZT halves HIV-1 perinatal transmission. Lancet 351: 651.
7. Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, et al. (1999) Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet 353: 781-785.
8. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, et al. (1999) 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mere-Enfant. Lancet 353: 786-792.
9. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, et al. (1999) Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353: 773-780.
10. World Health Organization (2004) Scaling up antiretroviral therapy in resource limited settings: Treatment Guidelines for a public health approach. Geneva.
11. WHO (2006) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resources limited settings. Towards universal health care. Geneva, Switzerland.
12. Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, et al. (2004) Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 189: 2154-2166.
13. Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, et al. (2007) Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med 4: e257.
14. Cayemittes M, Placide MF, Mariko S, Barrère B, Sévère B, et al. (2005) ENQUĚTE MORTALITÉ, MORBIDITÉ ET UTILISATION DES SERVICES EMMUS-IV 2005-2006. Calverton Maryland USA: Ministère de la Santé Publique et de la Population (MSPP), Institut Haïtien de l'Enfance (IHE), Macro International Inc.
15. Severe P, Leger P, Charles M, Noel F, Bonhomme G, et al. (2005) Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 353: 2325-2334.
16. George E, Noel F, Bois G, Cassagnol R, Estavien L, et al. (2007) Antiretroviral therapy for HIV-1-infected children in Haiti. J Infect Dis 195: 1411-1418.
17. Jean SS, Pape JW, Verdier RI, Reed GW, Hutto C, et al. (1999) The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J 18: 58-63.
18. Newell ML, Brahmbhatt H, Ghys PD (2004) Child mortality and HIV infection in Africa: a review. Aids 18 Suppl 2: S27-34.
19. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, et al. (2004) Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis Lancet 364: 1236-1243.
20. Taha TE, Kumwenda NI, Broadhead RL, Hoover DR, Graham SM, et al. (1999) Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 18: 689-694.
21. H Murphy JM, Ulysse J, Augustin A, Berggren R (2004) Mobile Clinic Voluntary Counseling and Testing and Prevention of Mother-to-child Transmission of HIV in Rural Haiti. Poster Exhibition: The XV International AIDS Conference: Abstract no. ThPeB7142. Bangkok, Thailand.
22. Madon T, Hofman KJ, Kupfer L, Glass RI (2007) PUBLIC HEALTH: Implementation Science 10.1126/science.1150009. Science 318: 1728-1729.
23. WHO/UNICEF/UNU (2001) Iron Deficiency Anaemia. Assessment, Prevention and Control.
24. Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, et al. (2007) International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol 197: S42-55.
25. Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E (2003) Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet 362: 667.
26. Stringer JS, Sinkala M, Maclean CC, Levy J, Kankasa C, et al. (2005) Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. Aids 19: 1309-1315.
27. Wei R, Msamanga GI, Spiegelman D, Hertzmark E, Baylin A, et al. (2004) Association between low birth weight and infant mortality in children born to human immunodeficiency virus 1-infected mothers in Tanzania. Pediatr Infect Dis J 23: 530-535.
28. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Lutalo T, et al. (2006) Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr 41: 504-508.
29. Ekouevi DK T-GB, Becquet R, Coffie P, Toure P, Leroy V, VIHO I, Blanche S, Dabis F, Abrams EJ. Low birth weight with nevirapine-based antiretroviral therapy in Abidjan Cote d'Ivoire. The ANRS DItrame Plus Cohort and MTCT-PLus Inititative 2001-2007[abstract 641]. 2008 Feb 3-6, 2008; Boston, Massachusetts.
30. Ryan M, Griffin S, Chitah B, Walker AS, Mulenga V, et al. (2008) The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. Aids 22: 749-757.
31. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, et al. (2004) Cotrimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 364: 1865-1871.
32. Noel F, Wright PF, Bois G, Deschamps MM, de Matteis P, et al. (2006) Contribution of bacterial sepsis to morbidity in infants born to HIV-infected Haitian mothers. J Acquir Immune Defic Syndr 43: 313-319.
33. WHO (2006) WHO HIV and Infant Feeding Technical Consultation. Held on Behalf of the Inter-agency Task Team (IATT) on Prevention of HIV infections in Pregnant Women, Mothers and their Infants. Consensus Statement. Geneva. pp 1-5.
34. Kourtis AP, Jamieson DJ, de Vincenzi I, Taylor A, Thigpen MC, et al. (2007) Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol 197: S113-122.
35. Peck R, Fitzgerald DW, Liautaud B, Deschamps MM, Verdier RI, et al. (2003) The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000. J Acquir Immune Defic Syndr 33: 470-475.
36. (1998) Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission-Thailand, 1996-1998. MMWR Morb Mortal Wkly Rep 47: 151-154.
37. Connor EM, Mofenson LM (1995) Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076-results and treatment recommendations. Pediatr Infect Dis J 14: 536-541.
38. Deschamps MM, Noel F, Bonhomme G, Devieux JG, Samuels D. Prevention of Mother to Child Transmission of HIV-1 In Haiti. Revista Panamericana de Salud Publica/Pan American Journal of Public Health: in press.
39. UNAID/WHO (2000) Use of co-trimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa: recommendations and operational issues. Geneva: Joint United Nations Programme on HIV/AIDS.
40. Temmerman M, Quaghebeur A, Mwanyumba F, Mandaliya K (2003) Mother-to-child HIV transmission in resource poor settings: how to improve coverage? Aids 17: 1239-1242.
41. Respess RA, Rayfield MA, Dondero TJ (2001) Laboratory testing and rapid HIV assays: applications for HIV surveillance in hard-to-reach populations. Aids 15 Suppl 3: S49-59.
42. George E, Beauharnais CA, Brignoli E, Noel F, Bois G, et al. (2007) Potential of a Simplified p24 Assay for Early Diagnosis of Infant Human Immunodeficiency Virus Type 1 Infection in Haiti. J Clin Microbiol 45: 3416-3418.
43. Magder LS, Mofenson L, Paul ME, Zorrilla CD, Blattner WA, et al. (2005) Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr 38: 87-95.
44. Lipsitz SR, Zhao LP, Molenberghs G (1998) A semiparametric method of multiple imputation doi:10.1111/1467-9868.00113. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 60: 127-144.